3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
76
Leukemia, Myeloid, Acute
71
Prostatic Neoplasms
67
Neoplasm Metastasis
56
Carcinoma, Non-Small-Cell Lung
56
Breast Neoplasms
45
Multiple Myeloma
44
Colorectal Neoplasms
41
Pancreatic Neoplasms
37
Myelodysplastic Syndromes
35
Carcinoma, Renal Cell
33
Ovarian Neoplasms
31
Melanoma
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Glioblastoma
27
Triple Negative Breast Neoplasms
26
Lymphoma, Large B-Cell, Diffuse
26
Urinary Bladder Neoplasms
24
Lymphoma
23
Burkitt Lymphoma
22
Squamous Cell Carcinoma of Head and Neck
21
Glioma
20
Fallopian Tube Neoplasms
20
Carcinoma, Hepatocellular
18
Mouth Neoplasms
17
Leukemia, Biphenotypic, Acute
17
Brain Neoplasms
17
Sarcoma
16
Oropharyngeal Neoplasms
16
Interventions
Cisplatin
57
Pemetrexed
45
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
atezolizumab
8
Drug Therapy
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mesothelioma, Malignant
×
Specimen Handling
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled